PNC Financial Services Group
ANRO icon

PNC Financial Services Group’s Alto Neuroscience ANRO Stock Holding History

PNC Financial Services Group’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.7K Sell
1,200
-6
-0.5% -$139 ﹤0.01% 3573
2026
Q1 		$27.1K Sell
1,206
-101
-8% -$1.87K ﹤0.01% 3551
2025
Q4 		$23.3K Sell
1,307
-159
-11% -$2K ﹤0.01% 3597
2025
Q3 		$5.89K Sell
1,466
-297
-17% -$985 ﹤0.01% 4141
2025
Q2 		$3.88K Buy
1,763
+1,621
+1,142% +$3.86K ﹤0.01% 4222
2025
Q1 		$306 Buy
+142
New +$508 ﹤0.01% 4724

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

PNC Financial Services Group's ANRO Position: Q2 2026 in Review

PNC Financial Services Group reduced its Alto Neuroscience (ANRO) stake by 0.5% in Q2 2026, selling an estimated $139 and leaving 1,200 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3573.

PNC Financial Services Group first reported a position in ANRO in Q1 2025 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • PNC Financial Services Group held 1,200 shares of Alto Neuroscience worth $31.7K as of Q2 2026.
  • PNC Financial Services Group sold 6 Alto Neuroscience shares in Q2 2026, an estimated $139.
  • Alto Neuroscience made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3573 holding.
  • PNC Financial Services Group first reported a position in Alto Neuroscience in Q1 2025 and has held it in 6 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.